Pine Tar

For most dermatological conditions, the dosage of Pine Tar is not measured in milligrams but rather in frequency of application and concentration of the product.

• Psoriasis and Eczema: Healthcare providers typically suggest applying a 2% to 5% Pine Tar cream or ointment to the affected areas 1 to 3 times daily. It is often recommended to apply the product after bathing when the skin is slightly damp to enhance penetration.
• Seborrheic Dermatitis (Scalp): Pine Tar shampoos should generally be used 2 to 3 times per week. The lather should be left on the scalp for 5 to 10 minutes before rinsing to allow the active constituents to penetrate the scales.
• General Pruritus: Pine Tar soap can be used daily in place of regular soap during flares of itchy skin.

Pine Tar is generally considered safe for pediatric use, but specific instructions should be followed:

• Infants (Cradle Cap): A mild Pine Tar solution or soap may be used once daily. It is crucial to avoid contact with the infant's eyes.
• Children with Atopic Dermatitis: Use the lowest effective concentration (often 1% or 2%) and limit application to the affected areas.
• Safety Note: Always consult a pediatrician before using Pine Tar on children under the age of 2, as their skin is thinner and more prone to systemic absorption.

Renal Impairment

Because systemic absorption of topical Pine Tar is minimal, dosage adjustments are typically not required for patients with kidney disease. However, if applied to very large surface areas of broken skin, caution is advised, and monitoring by a healthcare provider is recommended.

Hepatic Impairment

Similar to renal impairment, the low systemic bioavailability means that standard topical use does not usually require dose modification in patients with liver disease.

Elderly Patients

Elderly patients often have thinner, more fragile skin. While no specific dose reduction is mandated, healthcare providers may suggest starting with a lower frequency of application to monitor for skin irritation or 'tar acne.'

Pine Tar is for external use only. It should never be ingested.

1. 1Clean the Area: Gently wash the affected skin with mild, fragrance-free soap and pat dry before application.
2. 2Apply Thinly: Use only enough product to cover the affected area. Thick layers do not increase efficacy but do increase the risk of staining clothes and bedding.
3. 3Avoid Sensitive Areas: Do not apply to the eyes, mouth, nostrils, or genital area unless specifically directed by a doctor.
4. 4Sun Protection: Pine Tar can increase your skin's sensitivity to sunlight (photosensitivity). Use sunscreen and wear protective clothing over treated areas.
5. 5Storage: Store Pine Tar products at room temperature (15°C to 30°C or 59°F to 86°F) in a tightly closed container, away from direct heat and light.

If you miss an application of Pine Tar, apply it as soon as you remember. If it is almost time for your next scheduled application, skip the missed dose and return to your regular routine. Do not apply double the amount to make up for a missed dose.

While a 'toxic overdose' from topical application is extremely rare, excessive use can lead to severe skin irritation, chemical burns, or 'tar acne' (folliculitis).

• Signs of Overuse: Intense redness, burning, or the development of small, pus-filled bumps at the site of application.
• Accidental Ingestion: If Pine Tar is swallowed, contact a Poison Control Center immediately. Symptoms may include nausea, vomiting, and a distinct 'pine' or 'smoky' odor on the breath.
• Emergency Measures: For skin irritation, wash the area thoroughly with mild soap and water and discontinue use. For eye contact, flush with large amounts of water for at least 15 minutes.

> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose or frequency of use without medical guidance, as over-application can lead to skin damage.

Most patients tolerate Pine Tar well, but some may experience localized reactions. Common side effects include:

• Skin Irritation: A mild stinging or burning sensation immediately after application. This usually subsides within a few minutes.
• Contact Dermatitis: Redness, itching, or a rash at the site of application. This may indicate a mild sensitivity to one of the many compounds in the tar.
• Staining: Pine Tar is a dark, viscous substance that can temporarily stain the skin, hair (especially light-colored or treated hair), and clothing. This is a physical property of the drug rather than a biological side effect.
• Distinct Odor: The strong, smoky 'campfire' smell of Pine Tar can be bothersome to some patients and may linger on the skin for several hours.

• Folliculitis (Tar Acne): Pine Tar can clog the hair follicles, leading to small, red, itchy, or painful bumps that look like acne. This is more common when the product is used under occlusive (airtight) dressings.
• Photosensitivity: Increased sensitivity to ultraviolet (UV) light. Patients may find they sunburn more easily in areas where Pine Tar has been applied.
• Dryness: In some cases, the tar may cause the skin to become excessively dry or flaky after the initial inflammatory phase subsides.

• Severe Allergic Reactions: While rare, some individuals may develop a true Type IV hypersensitivity (delayed-type allergy) to Pine Tar, resulting in blistering or weeping skin.
• Systemic Toxicity: Only reported in cases of extreme overuse on severely damaged skin, symptoms could include headache, dizziness, or changes in urine color (darkening).

> Warning: Stop taking Pine Tar and call your doctor immediately if you experience any of these serious reactions:

• Anaphylaxis: Signs include hives, swelling of the face, lips, or tongue, difficulty breathing, or a rapid heartbeat. This is an emergency.
• Severe Chemical Burn: Intense, persistent burning, peeling, or blistering of the skin that does not stop after washing the product off.
• Infection: If the treated area develops spreading redness, warmth, swelling, or pus, it may indicate a secondary bacterial infection.
• Worsening of Condition: If the psoriasis or eczema spreads rapidly or becomes significantly more painful after starting treatment.

Chronic use of Pine Tar over many years has been a subject of clinical debate.

• Carcinogenicity Concerns: Older, crude coal tars contained high levels of polycyclic aromatic hydrocarbons (PAHs), which are known carcinogens. While Pine Tar is botanical and modern medical-grade versions are processed to minimize PAHs, some healthcare providers advise against continuous, uninterrupted use for decades. However, current data suggests that when used as directed, the risk of skin cancer from Pine Tar is extremely low.
• Skin Thinning: Unlike topical corticosteroids, Pine Tar does not typically cause skin atrophy (thinning), making it a safer option for long-term management of chronic conditions.

No FDA black box warnings for Pine Tar. It is generally considered a safe, low-risk therapeutic agent when used topically and as directed.

Report any unusual symptoms or persistent skin changes to your healthcare provider to ensure your treatment plan remains safe and effective.

Pine Tar is intended for topical use only. It must be kept out of the reach of children to prevent accidental ingestion. Patients should be aware that Pine Tar is a complex chemical mixture, and while it is 'natural,' natural substances can still cause potent biological effects and adverse reactions.

No FDA black box warnings for Pine Tar. Unlike some systemic immunosuppressants used for similar skin conditions, Pine Tar does not carry high-level warnings for malignancy or serious infection.

• Allergic Reactions / Anaphylaxis Risk: Individuals with a known allergy to pine pollen, pine nuts, or other coniferous products should exercise extreme caution. A 'patch test' (applying a small amount to a discrete area of skin for 24 hours) is recommended before widespread use.
• Photosensitivity: Pine Tar significantly increases the risk of phototoxicity. Patients should avoid tanning beds and prolonged sun exposure. If sun exposure is unavoidable, the treated area should be covered with UV-protective clothing.
• Broken or Infected Skin: Pine Tar should not be applied to skin that is actively oozing, infected, or has open wounds. This increases the risk of systemic absorption and may exacerbate the infection.
• Occlusive Dressings: Do not cover the treated area with plastic wrap, tight bandages, or other airtight dressings unless specifically instructed by a healthcare provider. This can increase the potency of the drug to dangerous levels and lead to folliculitis.
• Eye and Mucous Membrane Safety: Pine Tar is highly irritating to the eyes. If contact occurs, rinse immediately with water for 15 minutes. If irritation persists, seek ophthalmological evaluation.

For standard topical use, routine blood work (such as CBC or liver function tests) is typically not required. However, healthcare providers may perform:

• Skin Exams: Periodic evaluation of the treated areas to monitor for the development of unusual moles or skin lesions, especially with long-term use.
• Efficacy Assessment: Regular check-ins to ensure the condition is responding to treatment and has not transitioned into a state requiring systemic therapy (e.g., erythrodermic psoriasis).

Topical Pine Tar has no known effect on the ability to drive or operate heavy machinery. It does not cause drowsiness or impair cognitive function.

There are no known direct interactions between topical Pine Tar and alcohol consumption. However, alcohol can be a trigger for psoriasis and eczema flares in some patients, potentially reducing the perceived efficacy of the treatment.

Pine Tar does not cause physical dependence or a withdrawal syndrome. However, 'rebound' flares can occur if treatment is stopped abruptly in patients with severe psoriasis. It is often best to gradually reduce the frequency of application (tapering) as the skin clears, rather than stopping suddenly.

> Important: Discuss all your medical conditions, including any history of skin cancer or allergies, with your healthcare provider before starting Pine Tar.

While there are few absolute contraindications for topical Pine Tar, it should not be used simultaneously with:

• Other Tar Products (Coal Tar): Using multiple tar-based products together can significantly increase the risk of skin irritation and photosensitivity without providing additional therapeutic benefit.
• Topical Retinoids (e.g., Tretinoin, Adapalene): The combination can cause extreme skin irritation and peeling, as both agents affect the turnover rate of the epidermis.

• Methoxsalen (Psoralen): When used in PUVA (Psoralen + UltraViolet A) therapy, Pine Tar can potentiate the photosensitizing effects of methoxsalen, leading to severe burns. These should only be used together under strict medical supervision.
• Systemic Photosensitizing Drugs: Medications like tetracyclines, sulfonamides, or thiazide diuretics can increase sun sensitivity. Combining these with Pine Tar further elevates the risk of severe sunburn.

• Salicylic Acid: Often used in combination with tars to help remove scales. While effective, salicylic acid can increase the absorption of Pine Tar constituents. This combination should be used as formulated in commercial products rather than mixed manually.
• Topical Corticosteroids: These are often used in rotation with Pine Tar. While generally safe, using them at the exact same time on the same patch of skin may alter the absorption characteristics of both medications.

There are no known food interactions with topically applied Pine Tar. Because the medication is not absorbed through the digestive tract in significant amounts, dietary choices do not typically impact its efficacy or safety.

• St. John's Wort: Known to increase photosensitivity. Patients taking oral St. John's Wort while using topical Pine Tar should be especially vigilant about sun protection.
• Essential Oils: Applying concentrated essential oils (like tea tree or oregano oil) to the same area as Pine Tar may increase the risk of contact dermatitis.

Pine Tar is not known to interfere with standard blood or urine laboratory tests. However, if Pine Tar is present on the skin during a 'patch test' for allergies, it may cause a false-positive result for other resins or wood-derived allergens.

Mechanism of Interactions

Most interactions with Pine Tar are pharmacodynamic in nature, meaning they occur because two substances have similar or opposing effects on the skin (e.g., both increasing sun sensitivity). Because systemic levels are low, pharmacokinetic interactions (involving CYP450 enzymes in the liver) are clinically negligible for the topical form.

> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking, even those applied to the skin.

Pine Tar must NEVER be used in the following circumstances:

• Hypersensitivity: If you have had a previous severe allergic reaction (anaphylaxis or severe rash) to Pine Tar or any pine-derived product (e.g., colophony/rosin).
• Acute Inflammatory Psoriasis: In cases of erythrodermic or pustular psoriasis, where the skin is universally red and inflamed, Pine Tar may be too irritating and can worsen the condition.
• Infected Skin: Application to areas with active bacterial, viral (e.g., herpes), or fungal infections is contraindicated as it may mask or spread the infection.

Conditions requiring careful risk-benefit analysis by a healthcare provider:

• History of Skin Cancer: Due to the theoretical (though low) risk of carcinogenicity associated with long-term tar use, patients with a history of squamous cell carcinoma or melanoma should use Pine Tar only under close dermatological monitoring.
• Photosensitive Disorders: Patients with Lupus Erythematosus or Xeroderma Pigmentosum should avoid Pine Tar due to the increased risk of UV-induced skin damage.
• Pregnancy and Lactation: While not strictly contraindicated, the lack of robust clinical trials in these populations necessitates a cautious approach.

Patients who are allergic to the following substances may also react to Pine Tar:

• Balsam of Peru: Often cross-reacts with wood tars.
• Colophony (Rosin): A resin obtained from pines and other conifers.
• Turpentine: A fluid obtained by the distillation of resin obtained from live trees, mainly pines.
• Fragrance Mix: Many of the aromatic compounds in Pine Tar are also found in common perfumes and scented products.

> Important: Your healthcare provider will evaluate your complete medical history, including any previous skin reactions, before prescribing Pine Tar.

FDA Pregnancy Category: Not formally assigned (standard for many older OTC products).

• Risk Summary: There are no well-controlled studies of Pine Tar in pregnant women. While systemic absorption is low, the phenols and other compounds in the tar can theoretically cross the placental barrier if absorbed in sufficient quantities.
• Clinical Recommendation: Pine Tar should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. It is generally recommended to avoid application to large surface areas or for prolonged periods during the first trimester.

• Passage into Milk: It is unknown if the constituents of Pine Tar are excreted in human milk.
• Risk to Infant: The primary risk is 'contact exposure.' If Pine Tar is applied to the chest or breast area, the infant may ingest it or get it in their eyes during nursing.
• Recommendation: Avoid applying Pine Tar to the breast area while breastfeeding. If use is necessary, wash the area thoroughly before nursing.

• Approved Use: Pine Tar is commonly used for cradle cap and pediatric eczema.
• Safety: Children have a higher surface-area-to-body-weight ratio, which increases the risk of systemic absorption.
• Precautions: Use only the lowest effective concentration. Avoid use on infants under 6 months of age unless directed by a pediatrician. Monitor closely for signs of skin irritation.

• Pharmacokinetics: Older adults often have decreased skin lipid content and a thinner epidermal barrier, which may increase both the efficacy and the irritancy of Pine Tar.
• Polypharmacy: While systemic interactions are rare, elderly patients are more likely to be on systemic photosensitizing medications (like certain blood pressure pills), increasing the risk of sun-related side effects.
• Recommendation: Start with once-daily application and monitor for skin breakdown.

• Dosing: No specific dose adjustments are required for patients with mild to moderate renal impairment.
• Caution: In patients with end-stage renal disease (ESRD), avoid application to large areas of broken skin to prevent any potential accumulation of phenolic metabolites.

• Dosing: No specific adjustments are required. The liver's role in processing the minimal amounts of absorbed tar is generally sufficient even in the presence of mild hepatic dysfunction.

> Important: Special populations require individualized medical assessment. Always inform your doctor if you are pregnant, planning to become pregnant, or nursing before starting Pine Tar therapy.

Pine Tar acts as a keratoplastic agent. Its primary molecular effect is the suppression of DNA synthesis in the basal layers of the epidermis. By inhibiting the hyperproliferation of keratinocytes, it reduces the formation of scales and plaques. Additionally, Pine Tar contains various phenolic compounds (such as guaiacol and methylcreosote) that possess mild antiseptic and antifungal properties, which help to manage the microbial environment of the skin in conditions like seborrheic dermatitis.

In its role as a Nitrogen Binding Agent, the 'Ammonium Ion Binding Activity' is thought to involve the chemical sequestration of ammonia. Phenolic hydroxyl groups can interact with ammonium ions through hydrogen bonding and ionic interactions, effectively neutralizing them in the local environment.

• Onset of Action: Antipruritic effects (relief from itching) can be felt within 15-30 minutes of application. The keratoplastic effects (reduction in scaling) typically take 1 to 2 weeks of consistent use to become visible.
• Duration: The soothing effect usually lasts for 4 to 8 hours.
• Tolerance: There is no evidence that the skin develops 'tachyphylaxis' (tolerance) to Pine Tar, meaning it remains effective during long-term use.

| Parameter | Value |

|---|---|

| Bioavailability | <5% (Topical, intact skin) |

| Protein Binding | Unknown (Likely high for phenolic components) |

| Half-life | Not established for complex mixture |

| Tmax | 2-4 hours (Local tissue concentration) |

| Metabolism | Hepatic (Glucuronidation/Sulfation) |

| Excretion | Renal (>90% of absorbed fraction) |

• Molecular Formula: Complex mixture (Major components: $C_7H_8O_2$ for Guaiacol, $C_8H_{10}O_2$ for Methylcreosote).
• Molecular Weight: Variable (Mixture of low and high molecular weight polymers).
• Solubility: Insoluble in water; soluble in alcohol, ether, and chloroform.
• Structure: A dark brown to black, viscous liquid with a characteristic empyreumatic (smoky) odor.

Pine Tar is classified as a Standardized Insect Venom Allergenic Extract [EPC] and a Nitrogen Binding Agent [EPC]. In a therapeutic context, it is grouped with other topical keratolytics and antipruritics like Coal Tar, Ichthammol, and Sulfur.